415 CAPITAL Management GmbH announced that it has entered into a strategic alliance with Uniphar Group PLC. The partnership was formed on the back of Uniphar Group PLC’s acquisition of CoRRect Medical GmbH. The CoRRect Medical acquisition constitutes Uniphar Group PLC’s entry into Europe’s most important healthcare market, Germany, and also adds activities in Switzerland. CoRRect Medical GmbH will further complement the Uniphar Group’s existing strong position within the interventional space across a number of brands: EPS Vascular, Angiocare, M3, Synapse Medical and MacroMed.